Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.

Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs. Mol Endocrinol. 2013 Sep; 27(9):1403-14.

View in: PubMed